Lung Cancer - Small Cell News

Women Smokers Not at Greater Risk for Lung Cancer than Male Smokers (07/07/2008)
Women smokers may not be at greater risk for lung cancer than their male counterparts. These results were recently published in Lancet Oncology.

VePesid®/Platinol® Remains Standard-of-care for Small Cell Lung Cancer (06/07/2008)
For patients diagnosed with extensive-stage small-cell lung cancer (SCLC), the standard-of-care remains the chemotherapy combination of VePesid® (etoposide) and Platinol® (cisplatin). A recent study indicates that Camptosar® (irinotecan) plus Platinol does not improve survival in SCLC compared with VePesid/Platinol. These findings were presented at the 2008 annual meeting of the American Society of Clinical Oncology.

Blood Test Shows Promise for Early Detection of Lung Cancer (06/05/2008)
According to the results of a study presented at the 2008 annual meeting of the American Society of Clinical Oncology (ASCO), an experimental blood test may eventually allow for earlier detection of lung cancer in smokers.

Higher Chemotherapy Dose Intensity Does Not Improve Survival for Small Cell Lung Cancer (04/21/2008)
Increasing the dose intensity of chemotherapy does not appear to improve survival in small cell lung cancer. These results were recently published in the Journal of the National Cancer Institute.

Minimally Invasive Endoscopic Procedure Shows Promise for Detecting Lung Cancer (02/08/2008)
Use of a minimally invasive technique called endoscopy to detect lung cancer may be more effective than more complicated and invasive standard procedures. These findings were recently published in the Journal of the American Medical Association.

More...

Screening/Prevention

Women Smokers Not at Greater Risk for Lung Cancer than Male Smokers (07/07/2008)
Women smokers may not be at greater risk for lung cancer than their male counterparts. These results were recently published in Lancet Oncology.

Blood Test Shows Promise for Early Detection of Lung Cancer (06/05/2008)
According to the results of a study presented at the 2008 annual meeting of the American Society of Clinical Oncology (ASCO), an experimental blood test may eventually allow for earlier detection of lung cancer in smokers.

Minimally Invasive Endoscopic Procedure Shows Promise for Detecting Lung Cancer (02/08/2008)
Use of a minimally invasive technique called endoscopy to detect lung cancer may be more effective than more complicated and invasive standard procedures. These findings were recently published in the Journal of the American Medical Association.

Smoking Marijuana May Increase Risk of Lung Cancer (02/06/2008)
Smoking marijuana may increase the risk of lung cancer. However, this risk was only identified in patients who smoked the most marijuana over a decade or more. These findings were reported in the European Respiratory Journal.

Women Married to Smokers Have Increased Risk of Lung Cancer (01/08/2008)
According to the results of a combined analysis of previously published studies, nonsmoking women married to men who smoke are more likely to develop lung cancer than nonsmoking women married to nonsmoking men. These results were published in the International Journal of Epidemiology.

More...

Limited Disease

Higher Chemotherapy Dose Intensity Does Not Improve Survival for Small Cell Lung Cancer (04/21/2008)
Increasing the dose intensity of chemotherapy does not appear to improve survival in small cell lung cancer. These results were recently published in the Journal of the National Cancer Institute.

PET Scans May Help Identify Early Lung Cancer (11/28/2007)
According to an article recently published in the Journal of the National Cancer Institute, positron emission tomography (PET) scans may improve the accuracy of imaging in lung cancer.

Advances in the Management of Small-Cell Lung Cancer (03/25/2008)
Highlights from the 12th World Conference on Lung Cancer 

Possible Benefit of Surgery in Patients with Very Limited Small Cell Lung Cancer (03/09/2007)
According to the results of a study conducted in Italy, certain subsets of patients with small cell lung cancer (SCLC) may benefit from undergoing surgery after chemotherapy. These results were published in the Journal of Thoracic Oncology.

Dose-intensive Chemotherapy Improves Survival for Patients with Small Cell Lung Cancer (02/02/2007)
According to an article recently published in the Journal of Thoracic Oncology, intensified doses of the chemotherapy regimen referred to as ICE (ifosfamide, carboplatin, and etoposide) improve median survival compared to standard doses of ICE in the treatment of small cell lung cancer (SCLC).

More...

Extensive

VePesid®/Platinol® Remains Standard-of-care for Small Cell Lung Cancer (06/07/2008)
For patients diagnosed with extensive-stage small-cell lung cancer (SCLC), the standard-of-care remains the chemotherapy combination of VePesid® (etoposide) and Platinol® (cisplatin). A recent study indicates that Camptosar® (irinotecan) plus Platinol does not improve survival in SCLC compared with VePesid/Platinol. These findings were presented at the 2008 annual meeting of the American Society of Clinical Oncology.

Higher Chemotherapy Dose Intensity Does Not Improve Survival for Small Cell Lung Cancer (04/21/2008)
Increasing the dose intensity of chemotherapy does not appear to improve survival in small cell lung cancer. These results were recently published in the Journal of the National Cancer Institute.

PET Scans May Help Identify Early Lung Cancer (11/28/2007)
According to an article recently published in the Journal of the National Cancer Institute, positron emission tomography (PET) scans may improve the accuracy of imaging in lung cancer.

Camptosar® plus Paraplatin® Effective for Small Cell Lung Cancer (11/07/2007)
According to the results of a study presented at the 12^th World Lung Cancer Conference, chemotherapy with Camptosar® (irinotecan) and Paraplatin® (carboplatin) may result in better survival than chemotherapy with VePesid® (etoposide) and Paraplatin among patients with small cell lung cancer (SCLC).

Advances in the Management of Small-Cell Lung Cancer (03/25/2008)
Highlights from the 12th World Conference on Lung Cancer 

More...

Recurrent

Oral Hycamtin® Approved for Relapsed Small Cell Lung Cancer (10/15/2007)
The United States Food and Drug Administration has approved an oral capsule formulation of the chemotherapy agent Hycamtin® (topotecan) for the treatment of relapsed small cell lung cancer.

Further Results Show Improved Survival with Picoplatin for Small Cell Lung Cancer (09/04/2007)
According to results published in a press release by Poniard Pharmaceuticals, longer follow-up further indicates that the investigative chemotherapy agent picoplatin may improve survival compared to existing therapies in the treatment of patients diagnosed with small cell lung cancer who have previously received platinum-based therapies.

Addition of Gliadel® Wafer to Surgery and Radiation Effective for Brain Metastasis (06/22/2007)
According to an article in Clinical Cancer Research, the addition of Gliadel® Wafer (carmustine polymer wafer) to surgery plus external beam radiotherapy for the treatment of a single brain metastasis is a safe and effective regimen for patients.

Hycamtin® Improves Survival in Patients with Relapsed Small Cell Lung Cancer (12/06/2006)
According to the results of a study published in the Journal of Clinical Oncology, patients with relapsed small cell lung cancer survived longer if they were treated with the oral chemotherapy drug Hycamtin® (topotecan) than if they received no further chemotherapy.

Amrubicin Shows Promise in Relapsed or Refractory Small Cell Lung Cancer (11/30/2006)
According to a study published in the Journal of Clinical Oncology, treatment with the experimental chemotherapy drug amrubicin reduced or eliminated detectable cancer in roughly half of patients with previously-treated small cell lung cancer.

More...